IRCT20191223045870N1尚未招募3 期
The Effect of Betahistine on Weight- related and Metabolic Measures in Patients with Schizophrenia Treated with Olanzapine and Risperidone
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- All
入选标准
- •Patient or Legal Guardian Informed Consent
- •Have Schizophrenia Based on DSM5
- •18-59years old
- •Treated With Olanzapine or Risperidone That It Dosen't Change During The Study
- •Weight Gain At Least 7% Of Total Body Weight In The First Year of Treatment With Anti Psychotics Or In a Resent Year
- •If The Patient Is Taking Medication For Hyperlipidemia or Hypertention or Tyroid Disorders The Dose of Medication Did not Changed During The Study
- •The Patients Do not Have Another Medical or Psychiatric Disease
- •Do not Use Substance (Except Nicotine)
排除标准
- •Have Asthma
- •Have Peptic Ulcer
- •Have Pheochromocytoma
- •Liver and Kidney Disfunction
- •Treated with Other Weight Related Medications Like Sodium Valproarte or Weight loss or Appetite Suppressant Medications
- •Have Allergy to Betahistine
- •Pregnant or Lactating
研究者
相似试验
已完成
2 期
The Effect of Betahistine on Body Weight in Obese SubjectsObesityNCT00409305OBEcure Ltd.280
已完成
3 期
Aripiprazle in ADHD and ODDAttention deficit/hyperactivity disorder.Attention deficit/hyperactivity disorderIRCT20160530028182N6Sanandaj University of Medical Sciences76
已完成
2 期
Efficacy Study of Betahistine on Body Weight in Obese Female SubjectsObesityNCT00748436OBEcure Ltd.187
招募中
不适用
Effect of betahistine in treating in patients with peripheral vestibular diseaseperipheral vestibular diseaseJPRN-UMIN000032573niversity of Toyama15
已完成
不适用
Comparative fasting bioavailability of 2 different betahistine dihydrochloride 24-mg tablets: a single-dose, randomized-sequence, open-label, 2-period crossover study in healthy Thai volunteers.healthy volunteersbetahistine dihydrochlorideBioequivalenceTCTR20151106002Somruedee Chatsiricharoenkul24